Literature DB >> 12492389

Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies.

Paul M Bailey1, Mark Little, George A Jelinek, Jacqueline A Wilce.   

Abstract

Interest in envenoming syndromes caused by Australian jellyfish has been intense since the deaths in early 2002 of two tourists in Queensland, attributed to the Irukandji syndrome. We review current knowledge of these envenoming syndromes, mechanisms of venom action and therapy, focusing on the deadly box jellyfish, Chironex fleckeri, and the array of jellyfish thought to cause the Irukandji syndrome. Current understanding of jellyfish venom activity is very limited, and many treatments are unproven and based on anecdote.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492389     DOI: 10.5694/j.1326-5377.2003.tb05040.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Jellyfish and other cnidarian envenomations cause pain by affecting TRPV1 channels.

Authors:  Eva Cuypers; Angel Yanagihara; Evert Karlsson; Jan Tytgat
Journal:  FEBS Lett       Date:  2006-09-22       Impact factor: 4.124

2.  Evolution of box jellyfish (Cnidaria: Cubozoa), a group of highly toxic invertebrates.

Authors:  Bastian Bentlage; Paulyn Cartwright; Angel A Yanagihara; Cheryl Lewis; Gemma S Richards; Allen G Collins
Journal:  Proc Biol Sci       Date:  2009-11-18       Impact factor: 5.349

Review 3.  Interventions for the symptoms and signs resulting from jellyfish stings.

Authors:  Li Li; Richard G McGee; Geoff Isbister; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

Review 4.  Jellyfish stings and their management: a review.

Authors:  Luca Cegolon; William C Heymann; John H Lange; Giuseppe Mastrangelo
Journal:  Mar Drugs       Date:  2013-02-22       Impact factor: 5.118

5.  Isolation, Structure Determination, and Synthesis of Cyclic Tetraglutamic Acids from Box Jellyfish Species Alatina alata and Chironex yamaguchii.

Authors:  Justin Reinicke; Ryuju Kitatani; Shadi Sedghi Masoud; Kelly Kawabata Galbraith; Wesley Yoshida; Ayako Igarashi; Kazuo Nagasawa; Gideon Berger; Angel Yanagihara; Hiroshi Nagai; F David Horgen
Journal:  Molecules       Date:  2020-02-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.